About Semaglutide Capsules
Oral Semaglutide pairs the GLP-1 agonist with a SNAC absorption enhancer for once-daily oral dosing. Drives 15.1% weight loss at 68 weeks at 50 mg in the OASIS-1 readout.
Reported benefits
- Once-daily oral dosing - no injection
- Drives 15.1% weight loss at 68 weeks (OASIS-1)
- Appetite suppression within 1 week
Research citations
- Knop et al. 2023 - Lancet (OASIS-1)
- Davies et al. 2017 - JAMA
How Semaglutide Capsules fits the category
Semaglutide Capsules sits inside the Best Peptides for Weight Loss category. For the full ranking and head-to-head comparisons, read Best Peptides for Weight Loss.

